Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancer
Open Access
- 29 May 2025
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 58, 102432
Abstract
No abstract availableKeywords
Funding Information
- University of Texas System (RP210180)
- National Institute of General Medical Sciences (SC1GM140982\u201301)
- The University of Texas Rio Grande Valley, McAllen, TX
- Yale School of Management
- Cancer Prevention and Research Institute of Texas (RP230454)
- University of Texas Rio Grande Valley
- National Institutes of Health
This publication has 51 references indexed in Scilit:
- CEACAM7 expression contributes to early events of pancreatic cancerJournal of Advanced Research, 2023
- Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancerComputational and Structural Biotechnology Journal, 2023
- Identification of a novel alternatively spliced isoform of the ribosomal uL10 proteinBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2022
- Mitochondrial ribosomal small subunit (MRPS) MRPS23 protein–protein interaction reveals phosphorylation by CDK11-p58 affecting cell proliferation and knockdown of MRPS23 sensitizes breast cancer cells to CDK1 inhibitorsMolecular Biology Reports, 2022
- The Diseased MitoribosomeFEBS Letters, 2020
- Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regressionGene, 2020
- Gene signature associated with neuro‐endocrine activity predicting prognosis of pancreatic carcinomaMolecular Genetics & Genomic Medicine, 2019
- Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapiesGene, 2017
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 RegulationThe American Journal of Human Genetics, 2016
- Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid LeukemiaCancer Cell, 2011